Chemoinformaics analysis of 2,4-DIHYDROXY-2,5-DIMETHYL-3(2H)-FURANONE
| Molecular Weight | 144.126 | nRot | 0 |
| Heavy Atom Molecular Weight | 136.062 | nRig | 7 |
| Exact Molecular Weight | 144.042 | nRing | 1 |
| Solubility: LogS | -1.001 | nHRing | 1 |
| Solubility: LogP | -0.453 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 18.5623 |
| nHD | 2 | BPOL | 10.6297 |
| QED | 0.454 |
| Synth | 4.196 |
| Natural Product Likeliness | 1.487 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.001 |
| HIA | 0.008 |
| CACO-2 | -4.68 |
| MDCK | 0.0000454 |
| BBB | 0.936 |
| PPB | 0.176364 |
| VDSS | 0.618 |
| FU | 0.672337 |
| CYP1A2-inh | 0.025 |
| CYP1A2-sub | 0.802 |
| CYP2c19-inh | 0.03 |
| CYP2c19-sub | 0.782 |
| CYP2c9-inh | 0.005 |
| CYP2c9-sub | 0.058 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.193 |
| CYP3a4-inh | 0.005 |
| CYP3a4-sub | 0.501 |
| CL | 3.462 |
| T12 | 0.621 |
| hERG | 0.019 |
| Ames | 0.148 |
| ROA | 0.02 |
| SkinSen | 0.409 |
| Carcinogencity | 0.018 |
| EI | 0.93 |
| Respiratory | 0.73 |
| NR-Aromatase | 0.102 |
| Antiviral | No |
| Prediction | 0.945296 |